Hillman Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Hillman Capital Management's PFE Position: Q1 2026 in Review
Hillman Capital Management increased its Pfizer (PFE) stake by 7.2% in Q1 2026, buying an estimated $336K and bringing the position to 187,937 shares worth $5.28M. The position accounts for 3.66% of the portfolio, ranked #6.
Hillman Capital Management first reported a position in PFE in Q2 2013 and has held it in 21 quarters since. The position peaked at $8.49M in Q4 2024. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Hillman Capital Management held 187,937 shares of Pfizer worth $5.28M as of Q1 2026.
- Hillman Capital Management bought 12,633 Pfizer shares in Q1 2026, an estimated $336K.
- Pfizer made up 3.66% of Hillman Capital Management's portfolio in Q1 2026, its #6 holding.
- Hillman Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 21 quarters since.
- Hillman Capital Management's Pfizer position peaked at $8.49M in Q4 2024.
- 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Hillman Capital Management's 13F filing for Q1 2026, filed 15 May 2026.